Drugs
Drugs
Rockwell Medical Run-Up Trade Follows Financing
Tickers in this article: RMTI KERX
One trader believes Rockwell shares will rise into clinical trial results expected in July.
05/21/13 - 08:00 AM EDT
MORE NEWS FOR DRUGS
| Company | Last | %CHNG | Volume |
|---|---|---|---|
| MannKind Corporation (MNKD) | 6.23 | 16.23 | 23.25 M |
| AcelRx Pharmaceuticals Inc. (ACRX) | 7.26 | 13.44 | 1.00 M |
| iBio Inc. (IBIO) | 0.42 | 10.85 | 0.74 M |
| Rexahn Pharmaceuticals Inc. (RNN) | 0.39 | 10.75 | 4.20 M |
| Insmed Inc. (INSM) | 12.44 | 9.80 | 1.94 M |
| China Pharma Holding Inc. (CPHI) | 0.23 | 9.48 | 0.01 M |
| Vermillion Inc. (VRML) | 3.14 | 7.53 | 0.51 M |
| ImmuCell Corporation (ICCC) | 3.75 | 7.14 | 0.00 M |
| DARA Biosciences Inc. (DARA) | 0.76 | 7.04 | 0.35 M |
| Prima Biomed Ltd. (PBMD) | 2.57 | 6.98 | 0.00 M |
| Company | Last | %CHNG | Volume |
|---|---|---|---|
| Neuro-Hitech Incorporated (NHPI) | 0.01 | -15.79 | 0.01 M |
| AMAG Pharmaceuticals Inc. (AMAG) | 22.40 | -10.69 | 0.42 M |
| Neptune Technologies & Bioressources Inc. (NEPT) | 2.73 | -9.60 | 0.36 M |
| AVEO Pharmaceuticals Inc. (AVEO) | 2.66 | -8.28 | 2.70 M |
| Omeros Corporation (OMER) | 4.94 | -8.18 | 0.32 M |
| ProPhase Labs Inc. (PRPH) | 1.47 | -8.12 | 0.01 M |
| Infinity Pharmaceuticals Inc. (INFI) | 23.12 | -8.00 | 2.45 M |
| Astex Pharmaceuticals Inc (ASTX) | 5.20 | -7.64 | 1.29 M |
| TrovaGene Inc. (TROV) | 6.34 | -7.31 | 0.09 M |
| Catalyst Pharmaceutical Partners Inc. (CPRX) | 0.85 | -7.06 | 0.44 M |
| Company | Last | %CHNG | Volume |
|---|---|---|---|
| Pfizer Inc (PFE) | 29.30 | 1.81 | 83.54 M |
| Merck & Co Inc (MRK) | 46.71 | -1.31 | 42.62 M |
| Zoetis Inc (ZTS) | 33.55 | 1.54 | 25.90 M |
| Bristol-Myers Squibb Company (BMY) | 46.40 | 5.31 | 25.31 M |
| MannKind Corporation (MNKD) | 6.23 | 16.23 | 23.25 M |
| Warner Chilcott PLC (WCRX) | 20.25 | -1.75 | 16.58 M |
| Johnson & Johnson (JNJ) | 88.46 | -0.15 | 13.81 M |
| Elan Corp PLC (ELN) | 12.04 | -0.25 | 12.91 M |
| Gilead Sciences Inc (GILD) | 55.93 | -0.96 | 12.75 M |
| Mylan Inc (MYL) | 31.55 | 1.02 | 8.43 M |
| Company | Last | %CHNG | Mkt Cap |
|---|---|---|---|
| Johnson & Johnson (JNJ) | 88.46 | -0.15 | $247.2 B |
| Pfizer Inc (PFE) | 29.30 | 1.81 | $203.6 B |
| Novartis AG (NVS) | 74.62 | -0.01 | $182.2 B |
| Sanofi (SNY) | 55.05 | 0.00 | $144.4 B |
| GlaxoSmithKline PLC (GSK) | 52.94 | 0.55 | $140.9 B |
| Merck & Co Inc (MRK) | 46.71 | -1.31 | $136.5 B |
| Novo Nordisk A/S (NVO) | 169.55 | -0.93 | $94.4 B |
| Gilead Sciences Inc (GILD) | 55.93 | -0.96 | $85.0 B |
| Amgen Inc (AMGN) | 104.53 | 0.28 | $76.6 B |
| AbbVie Inc (ABBV) | 46.76 | 0.47 | $73.3 B |
Featured Industry: Conglomerates
-
Broadcasters Fear the Music in Aereo Fight
As the ABC, NBC, CBS and Fox seek to block Aereo, they must be mindful not to make the mistakes that imploded the music industry 10 year ago.
5 Stocks With Big Insider Buying
Allocate Assets to Buy-Rated Dow Stocks
3M Stock To Go Ex-dividend Tomorrow (MMM)
5 Hold-Rated Dividend Stocks: NSH, SLRC, HRZN, NMFC, NRT
Partner Headlines
-
Market Close Report: NASDAQ Composite index closes at 3,206.06 up 39.70 points
-
After Hours Most Active for Apr 19, 2013 : PBR/A, CRM, PPL, DOW, GILD, MS, QQQ, EMC, DTV, DNDN, SQNM, YHOO
-
Pre-Market Most Active for Apr 19, 2013 : DELL, GE, VOD, QQQ, TOT, MSFT, BAC, VRTX, SAP, NOK, BIOS, DEO
-
Stocks Up, Dow Turns Positive; Leaders Catch An Updraft
-
Companies slide $181B through tax loopholes
-
UPDATE: Credit Suisse Raises PT on Vertex Pharmaceuticals on Cystic Fibrosis Franchise De-Risking
-
Futures Geared For Higher Open; Vertex, Google, Chipotle Rumble
-
Protect Yourself From Gold
-
Stocks Take Another Drubbing, But Google Rises After Hours
-
Stocks' Losses Mount After Lousy Manufacturing Data
PR / BWire
-
Amgen Announces Voting Results Of Annual Meeting Of Stockholders
-
Chembio Appoints Sharon Klugewicz As Chief Operating Officer
-
Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of AMAG Pharmaceuticals, Inc.
-
Apricus Biosciences Announces Proposed Public Offering Of Common Stock And Warrants
-
TESARO To Present At The Deutsche Bank 38th Annual 2013 Health Care Conference
-
CORRECTION FROM SOURCE: Neptune Reports Fiscal 2013 Results And Provides Update On Action Plan To Resume Operations
-
Celldex Therapeutics To Present At Two Upcoming Investor Conferences
-
Generex Announces ASCO Presentations On The Antigen Express Advanced Stage AE37 Cancer Vaccine
-
Avanir Pharmaceuticals To Participate In Two Upcoming Investor Conferences
-
Neptune Reports Fiscal 2013 Results And Provides Update On Action Plan To Resume Operations
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
Latest Market Update
04:25PM 05/22/13
NEW YORK (TheStreet) -- U.S. markets on Wednesday erased morning gains, falling sharply after theFederal Reserve's minutes from its latest policy-making meeting showed that some members are open to scaling back monetary stimulus by June.
The minutes came hours after Fed Chairman Ben Bernanke reiterated his support of current monetary policy and argued that a pull-back in quantitative easing wouldn't be a prudent move.
"A number of participants expressed willingness to adjust the flow of purchases downward as early as the June meeting if the economic information received by that time showed evidence of sufficiently strong and sustained growth," the minutes said. ...
MoreBrokerage Partners
|
|
|
|
|
|
|
|
|
|
|
|